Zdrowie i gospodarka · 19/09/2024

FDA Announces Fee Rate for Using a Priority Review Voucher in Fiscal Year 2025

The Food and Drug Administration (FDA) has announced the fee rate for using a priority review voucher for fiscal year 2025. The fee rate is determined by the difference between the average cost of reviewing a priority review application and a non-priority review application from the previous fiscal year.